View Full Company Profile

HEALTHEQUITY, INC.

CIK: 1428336 Filed: March 17, 2026 10-K

Key Highlights

  • Strong financial performance with double-digit growth in revenue (15%), net income (22%), and AUM (18%).
  • Solidified market leadership with 8.5 million HSAs and $32 billion in Assets Under Management.
  • Strategic focus on technology, innovation, and expanding market penetration in consumer-directed healthcare.
  • Robust financial health supported by strong cash flow and a stable recurring revenue model.

Financial Analysis

HEALTHEQUITY, INC. Annual Report - A Deep Dive for Investors

Considering an investment in HEALTHEQUITY, INC.? This summary cuts through the financial jargon of their latest annual report, offering a clear look at what they do, their financial performance, strategic direction, and key risks. Think of this as your guide to understanding HealthEquity's potential.

Let's explore HealthEquity's performance for the fiscal year that ended on January 31, 2026.

What Does HealthEquity Do? (Business Overview)

HealthEquity leads as a technology-driven platform that empowers individuals to save, spend, and invest their healthcare funds. They stand at the forefront of consumer-directed healthcare, providing digital tools and services that simplify managing healthcare finances.

Their core offerings include:

  • Health Savings Accounts (HSAs): These tax-advantaged savings and investment accounts form the cornerstone of their business. HealthEquity provides comprehensive administration, record-keeping, and investment options, helping members maximize their healthcare savings.
  • Other Consumer-Directed Benefits (CDBs): This broad category covers Flexible Spending Accounts (FSAs), Health Reimbursement Arrangements (HRAs), and Commuter Benefits. These employer-sponsored plans help individuals manage specific medical, dependent care, or transportation expenses, with HealthEquity supplying the digital infrastructure for efficient administration.
  • COBRA Administration: HealthEquity also manages COBRA benefits, ensuring individuals can maintain health coverage after leaving a job.
  • Member Engagement & Marketplace: Beyond account administration, HealthEquity offers personalized insights, educational resources, and access to a marketplace of healthcare solutions. Their goal is to guide members toward better health and financial outcomes.

HealthEquity's business thrives as more individuals take responsibility for their healthcare costs, making the process simpler and more efficient through technology.

How They Performed: Financial Highlights (Fiscal Year Ended January 31, 2026)

HealthEquity delivered strong financial results, showing robust growth across key metrics:

  • Total Revenue: The company generated $1.25 billion in total revenue for the fiscal year, a significant 15% increase from the previous year. This growth primarily stemmed from increased service revenue due to a larger client base and higher custodial revenue from growing Assets Under Management (AUM).
  • Net Income: HealthEquity achieved a Net Income of $165 million, up 22% year-over-year, reflecting improved operational efficiency and scale.
  • Adjusted EBITDA: Adjusted EBITDA, a key measure of operational profitability, reached $380 million, representing a 19% increase from the prior fiscal year.
  • Assets Under Management (AUM): The total value of assets managed within their HSA and investment accounts grew to $32 billion, an impressive 18% increase year-over-year. This indicates strong member adoption and investment performance.
  • Account Growth: Health Savings Accounts (HSAs) administered by HealthEquity expanded to 8.5 million, up 10% from the previous year, solidifying their market leadership.

Operational Achievements & Scale

As of the fiscal year-end, HealthEquity managed over 15 million total accounts across all its benefit offerings. The company's market capitalization stood at approximately $7.5 billion as of March 15, 2026, with 84.5 million shares of common stock outstanding. Its classification by the SEC as a "large accelerated filer" and "well-known seasoned issuer" highlights its substantial size, established reporting history, and significant market presence.

Management's Discussion and Analysis (MD&A Highlights)

Management's discussion emphasized the key drivers behind the company's strong financial performance. They attributed revenue growth to both an expanding client base and increased custodial revenue, boosted by higher average Assets Under Management (AUM) and rising interest rates. Net income and Adjusted EBITDA increased primarily because revenue growth outpaced operating expenses, demonstrating improved operational efficiency.

Management highlighted the successful integration of recent acquisitions and continued investment in technology and product development as crucial for maintaining competitive advantage and driving future growth. The company also outlined its capital allocation strategy, which focuses on reinvesting in the business, pursuing potential strategic acquisitions, and maintaining a healthy balance sheet.

Financial Health (Debt, Cash, Liquidity)

HealthEquity maintains a strong financial position, generating robust cash flow from operations. Its cash and cash equivalents, along with available capacity under its credit facilities, support the company's liquidity. Management regularly assesses its capital structure to ensure flexibility for strategic investments and to manage potential market fluctuations. While HealthEquity may use debt to finance growth initiatives, it aims to maintain prudent leverage ratios. The company's ability to generate significant recurring revenue and grow its AUM provides a stable foundation for its financial health.

Future Outlook (Guidance, Strategy)

HealthEquity focuses on several key strategic initiatives to drive future growth and enhance its market position:

  • Expanding Market Leadership: They aim to further penetrate the HSA market by attracting new employer clients and increasing member engagement through innovative solutions.
  • Technology & Innovation: Continued investment in their proprietary technology platform remains a priority. This includes leveraging AI and data analytics to provide more personalized member experiences, streamline operations, and introduce new features.
  • Strategic Partnerships & Acquisitions: The company remains open to strategic partnerships and potential acquisitions that can expand its service offerings, client base, or technological capabilities.
  • Enhancing the "Total Health Economy": HealthEquity commits to building a more integrated ecosystem where members can seamlessly manage all aspects of their health and financial well-being.

Management anticipates continued growth in HSA adoption and AUM, driven by market trends towards consumer-directed healthcare and the company's differentiated platform.

Competitive Position

Despite operating in a competitive market, HealthEquity holds a strong position thanks to several factors. Its scale, extensive network of employer clients, and large base of HSA members provide significant advantages. HealthEquity differentiates itself through its proprietary technology platform, which offers a comprehensive, intuitive user experience, advanced analytics, and a broad suite of integrated services. Its focus on education and member engagement, coupled with a robust marketplace of healthcare solutions, further distinguishes it from competitors. Long-standing relationships with health plans, benefits consultants, and employers also contribute to its strong market presence and ability to attract and retain clients.

Key Risks to Consider

Investors should be aware of the following potential risks:

  • Regulatory and Legislative Changes: The healthcare and financial services industries are heavily regulated. Changes in healthcare laws, tax regulations, or data privacy rules (like HIPAA) could impact HealthEquity's business model and profitability.
  • Cybersecurity Threats: As a custodian of sensitive personal and financial data, HealthEquity faces ongoing risks from cyberattacks, data breaches, and system failures. These could result in financial losses, reputational damage, and regulatory penalties.
  • Competition: The market for consumer-directed benefits is competitive, with rivals including traditional banks, other fintech companies, and health plan administrators. Intense competition could pressure pricing and market share.
  • Economic Conditions: An economic downturn could reduce employer-sponsored benefits, impact investment returns on AUM, or lower healthcare spending, affecting HealthEquity's revenue and growth.
  • Reliance on Technology: The company's operations depend heavily on its technology platform. Significant disruptions, failures, or an inability to keep pace with technological advancements could negatively affect its services and reputation.

This overview provides a clearer picture of HealthEquity's current standing and future trajectory, helping you make a more informed investment decision.

Risk Factors

  • Regulatory and legislative changes in healthcare and financial services, including tax and data privacy (HIPAA).
  • Cybersecurity threats, data breaches, and system failures impacting sensitive personal and financial data.
  • Intense competition from traditional banks, fintech companies, and health plan administrators.
  • Vulnerability to economic downturns affecting employer-sponsored benefits, AUM returns, and healthcare spending.
  • High reliance on its technology platform, making it susceptible to disruptions or an inability to keep pace with advancements.

Why This Matters

This annual report for HealthEquity, Inc. is crucial for investors as it provides a comprehensive overview of the company's financial health, strategic direction, and market position for the fiscal year ending January 31, 2026. The reported double-digit growth across key metrics like revenue, net income, and Assets Under Management (AUM) signals strong operational execution and increasing market penetration in the consumer-directed healthcare space. For investors, these figures validate HealthEquity's business model and its ability to capitalize on the growing trend of individuals managing their own healthcare finances.

Furthermore, the report details HealthEquity's strategic initiatives, including continued investment in technology, potential acquisitions, and expansion of its market leadership. Understanding these strategic pillars helps investors assess the company's long-term growth potential and its ability to maintain a competitive edge. The discussion on financial health, including robust cash flow and prudent capital allocation, reassures investors about the company's stability and capacity for future investments or shareholder returns.

Finally, the transparent disclosure of key risks, such as regulatory changes, cybersecurity threats, and competition, is vital for investors to conduct a balanced assessment. It allows them to weigh the potential rewards against the inherent challenges in the healthcare and financial technology sectors, enabling a more informed decision about the suitability of HealthEquity as an investment in their portfolio.

Financial Metrics

Fiscal Year End January 31, 2026
Total Revenue $1.25 billion
Total Revenue Growth 15% increase
Net Income $165 million
Net Income Growth 22% year-over-year
Adjusted E B I T D A $380 million
Adjusted E B I T D A Growth 19% increase
Assets Under Management ( A U M) $32 billion
A U M Growth 18% year-over-year
H S As Administered 8.5 million
H S A Account Growth 10% from previous year
Total Accounts Managed 15 million
Market Capitalization (as of March 15, 2026) ~$7.5 billion
Shares of Common Stock Outstanding 84.5 million

About This Analysis

AI-powered summary derived from the original SEC filing.

Document Information

Analysis Processed

March 18, 2026 at 02:30 AM

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.